Cargando…

CI Therapy is Beneficial to Patients with Chronic Low-Functioning Hemiparesis after Stroke

CI therapy is effective in patients with relatively good levels of residual arm function but its applicability to patients with low-functioning hemiparesis is not entirely clear. In the present study, we examined the feasibility and efficacy of the CI therapy concept in patients with very limited up...

Descripción completa

Detalles Bibliográficos
Autores principales: Sterr, Annette, O’Neill, Darragh, Dean, Philip J. A., Herron, Katherine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202624/
https://www.ncbi.nlm.nih.gov/pubmed/25368598
http://dx.doi.org/10.3389/fneur.2014.00204
_version_ 1782340326310019072
author Sterr, Annette
O’Neill, Darragh
Dean, Philip J. A.
Herron, Katherine A.
author_facet Sterr, Annette
O’Neill, Darragh
Dean, Philip J. A.
Herron, Katherine A.
author_sort Sterr, Annette
collection PubMed
description CI therapy is effective in patients with relatively good levels of residual arm function but its applicability to patients with low-functioning hemiparesis is not entirely clear. In the present study, we examined the feasibility and efficacy of the CI therapy concept in patients with very limited upper arm function prior to treatment, and further tested how the length of daily shaping training and constraining the good arm affects treatment outcome. In a baseline-controlled design, 65 chronic patients were treated with 2 weeks of modified CI therapy. Patients were randomly allocated to four treatment groups receiving 90 or 180 min of daily shaping training applied with or without constraint, respectively. Outcome was measured through the Reliable Change Index, which was calculated for parameters of motor function, health, and psychological wellbeing. Follow-up data were collected at 6 and 12 months. Two analyses were conducted, a whole-group analysis across all 65 participants and a sub-group analysis contrasting the four treatment variants. The whole-group analysis showed a significant treatment effect, which was largely sustained after 1 year. The sub-group analysis revealed a mixed picture; while improvements against the baseline period were observed in all four subgroups, 180 min of daily shaping training coupled with the constraint yielded better outcome on the MAL but not the WMFT, while for 90 min of training the level of improvement was similar for those who wore the constraint and those who did not. Together these results suggest that, at least in those patients available for follow-up measures, modified CI therapy induces sustained improvements in motor function in patients with chronic low-functioning hemiparesis. The absence of clear differences between the four treatment variants points to a complex relationship between the length of daily shaping training and the constraint in this patient group, which is likely to be mediated by fatigue and/or compliance with the constraint.
format Online
Article
Text
id pubmed-4202624
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-42026242014-11-03 CI Therapy is Beneficial to Patients with Chronic Low-Functioning Hemiparesis after Stroke Sterr, Annette O’Neill, Darragh Dean, Philip J. A. Herron, Katherine A. Front Neurol Neuroscience CI therapy is effective in patients with relatively good levels of residual arm function but its applicability to patients with low-functioning hemiparesis is not entirely clear. In the present study, we examined the feasibility and efficacy of the CI therapy concept in patients with very limited upper arm function prior to treatment, and further tested how the length of daily shaping training and constraining the good arm affects treatment outcome. In a baseline-controlled design, 65 chronic patients were treated with 2 weeks of modified CI therapy. Patients were randomly allocated to four treatment groups receiving 90 or 180 min of daily shaping training applied with or without constraint, respectively. Outcome was measured through the Reliable Change Index, which was calculated for parameters of motor function, health, and psychological wellbeing. Follow-up data were collected at 6 and 12 months. Two analyses were conducted, a whole-group analysis across all 65 participants and a sub-group analysis contrasting the four treatment variants. The whole-group analysis showed a significant treatment effect, which was largely sustained after 1 year. The sub-group analysis revealed a mixed picture; while improvements against the baseline period were observed in all four subgroups, 180 min of daily shaping training coupled with the constraint yielded better outcome on the MAL but not the WMFT, while for 90 min of training the level of improvement was similar for those who wore the constraint and those who did not. Together these results suggest that, at least in those patients available for follow-up measures, modified CI therapy induces sustained improvements in motor function in patients with chronic low-functioning hemiparesis. The absence of clear differences between the four treatment variants points to a complex relationship between the length of daily shaping training and the constraint in this patient group, which is likely to be mediated by fatigue and/or compliance with the constraint. Frontiers Media S.A. 2014-10-20 /pmc/articles/PMC4202624/ /pubmed/25368598 http://dx.doi.org/10.3389/fneur.2014.00204 Text en Copyright © 2014 Sterr, O’Neill, Dean and Herron. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Sterr, Annette
O’Neill, Darragh
Dean, Philip J. A.
Herron, Katherine A.
CI Therapy is Beneficial to Patients with Chronic Low-Functioning Hemiparesis after Stroke
title CI Therapy is Beneficial to Patients with Chronic Low-Functioning Hemiparesis after Stroke
title_full CI Therapy is Beneficial to Patients with Chronic Low-Functioning Hemiparesis after Stroke
title_fullStr CI Therapy is Beneficial to Patients with Chronic Low-Functioning Hemiparesis after Stroke
title_full_unstemmed CI Therapy is Beneficial to Patients with Chronic Low-Functioning Hemiparesis after Stroke
title_short CI Therapy is Beneficial to Patients with Chronic Low-Functioning Hemiparesis after Stroke
title_sort ci therapy is beneficial to patients with chronic low-functioning hemiparesis after stroke
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202624/
https://www.ncbi.nlm.nih.gov/pubmed/25368598
http://dx.doi.org/10.3389/fneur.2014.00204
work_keys_str_mv AT sterrannette citherapyisbeneficialtopatientswithchroniclowfunctioninghemiparesisafterstroke
AT oneilldarragh citherapyisbeneficialtopatientswithchroniclowfunctioninghemiparesisafterstroke
AT deanphilipja citherapyisbeneficialtopatientswithchroniclowfunctioninghemiparesisafterstroke
AT herronkatherinea citherapyisbeneficialtopatientswithchroniclowfunctioninghemiparesisafterstroke